Home>Topics>Companies>Abbott Laboratories

Abbott Laboratories ABT

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Abbott to report on October 22

      Headlines

      Wed, 1 Oct 2014

      Abbott ( ABT -0.6% ) will report Q3 results on October 22 before the open. The conference call and webcast will start at 8:00 am CT. Consensus view is EPS of $0.59 on revenues of $5.62B. Post your comment!

    2. Premature Combination Use Of Belviq And Phentermine Is A Risk

      Headlines

      Sun, 28 Sep 2014

      have had poor market success and notable safety issues. Meridia [ Sibutramine ] was withdrawn from the market by Abbott ( NYSE : ABT ) because it was associated with an increase in ma jor adverse cardiovascular events [MACE] in the SCOUT trial. The market

    3. Abbott, AbbVie win dismissal of claims over Humira, AndroGel

      Headlines

      Thu, 25 Sep 2014

      Sept 25 (Reuters) - A federal judge in Chicago dismissed racketeering claims in a lawsuit accusing Abbott Laboratories and AbbVie Inc of causing health plans to pay unnecessarily for the latter's blockbuster Humira arthritis drug and AndroGel

    4. Hesitation In The Medical Device ETF: Just A Bump In The Road?

      Headlines

      Fri, 19 Sep 2014

      this lofty price and outperformance scare investors a bit? Perhaps. Some of the ETFs top holdings, such as Abbott Labs ( NYSE : ABT ) or Stryker (NYSE: SYK ) are selling at or near the top of the PE range of the last ten years. However

    5. Update: Abbott To Invest $60 Million In An Intraocular Lens Plant In Malaysia

      Headlines

      Mon, 15 Sep 2014

      By Andy Batts : Abbott ( NYSE : ABT ) will invest $60 million in an intraocular lens ("IOLs") manufacturing plant in Malaysia, FierceMedicalDevices reports

    6. Abbott to buy back more shares

      Headlines

      Fri, 12 Sep 2014

      Abbott Laboratories ' ( ABT ) BOD authorizes the repurchase of up to $3B of the company's common shares. This is in addition to the $511M unused portion

    7. Abbott Laboratories declares $0.22 dividend

      Headlines

      Thu, 11 Sep 2014

      Abbott ( NYSE : ABT ) declares $0.22/share quarterly dividend , in line with previous. Forward yield 2.06% Payable Nov. 15; for shareholders of record Oct. 15; ex-div Oct. 13. Post your comment!

    8. Abbott Is Getting Expensive On A Fundamental Basis

      Headlines

      Thu, 11 Sep 2014

      By Abba's Aces : The last time I analyzed Abbott Laboratories ( NYSE : ABT ) on July 5, 2014, I stated, "Like I said, I will only be buying a small batch this time around, only for the dividend

    9. Johnson & Johnson: The One Stock You Should Ever Own?

      Headlines

      Tue, 9 Sep 2014

      of your eggs in one basket." There are exceptions, however, such as the woman who bought 3 shares of Abbott Laboratories ( NYSE : ABT ) for $180 in 1935, and ended up donating about $7 million to a local college from her ABT investment

    10. Abbott glucose monitor cleared in Europe

      Headlines

      Wed, 3 Sep 2014

      Abbott Laboratories ( ABT +0.8% ) earns CE Mark clearance for its FreeStyle Libre Flash Glucose Monitoring System for people with diabetes. The system

    « Prev12345Next »
    Content Partners